drugset
Drugs / omega-3 enriched SMOF lipid emusion
last change Jan 2018 re-read 3 minutes ago

omega-3 enriched SMOF lipid emusion

also known as SMOF lipid
Developed for
traumatic brain injury
Investigated by
Mansoura University

Trials 1

today NCT02762539 · not/applicable
20172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
— NCT02762539 Jun 2016 → Jan 2018 traumatic brain injury Mansoura University Unknown No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as omega-3 enriched SMOF lipid emusion ClinicalTrials.gov intervention name — accepted as the source's own label NCT02762539 ↗
Known as SMOF lipid “0.5 g/Kg SMOF lipid 10% emulsion (Lipid emulsion for intravenous nutrition containing; 6% soybean oil / 6% medium chain triglycerides / 5% olive oil / 3%fish oil)” NCT02762539 ↗
Route Intravenous “Lipid emulsion for intravenous nutrition containing; 6% soybean oil / 6% medium chain triglycerides / 5% olive oil / 3%fish oil” NCT02762539 ↗